Citadel Advisors »

Impact Biomedical shares owned by Citadel Advisors

Quarter-by-quarter ownership of Impact Biomedical (IBO) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Impact Biomedical

Tip: Access up to 7 years of quarterly data

All positions including Impact Biomedical held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Impact Biomedical by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $23k 50k 0.46
2025-03-31 $53k 60k 0.87

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Micron Technology Call Option (MU)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Sandisk Corp (SNDK)
Advanced Micro Devices Call Option (AMD)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Amazon (AMZN)

View all positions for Citadel Advisors

Top funds holding Impact Biomedical

Geode Capital Management
Vanguard Capital Management
State Street Corporation
Vanguard Fiduciary Trust
BlackRock
Northern Trust
Citadel Advisors
Vanguard Global Advisers
Jane Street
Two Sigma Investments
Mason & Associates
Morgan Stanley
UBS Group
Global Trust Asset Management
Citigroup

View all funds holding Impact Biomedical